These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7371472)

  • 1. A non-transferrin-bound serum iron in idiopathic hemochromatosis.
    Batey RG; Lai Chung Fong P; Shamir S; Sherlock S
    Dig Dis Sci; 1980 May; 25(5):340-6. PubMed ID: 7371472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and hepatic metabolism of non-transferrin-bound iron.
    Batey RG; Shamir S; Wilms J
    Dig Dis Sci; 1981 Dec; 26(12):1084-8. PubMed ID: 7307855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy.
    Aruoma OI; Bomford A; Polson RJ; Halliwell B
    Blood; 1988 Oct; 72(4):1416-9. PubMed ID: 2458783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic iron clearance from serum in treated hemochromatosis.
    Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
    Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis.
    Craven CM; Alexander J; Eldridge M; Kushner JP; Bernstein S; Kaplan J
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3457-61. PubMed ID: 3472216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
    Grootveld M; Bell JD; Halliwell B; Aruoma OI; Bomford A; Sadler PJ
    J Biol Chem; 1989 Mar; 264(8):4417-22. PubMed ID: 2466835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method.
    Loréal O; Gosriwatana I; Guyader D; Porter J; Brissot P; Hider RC
    J Hepatol; 2000 May; 32(5):727-33. PubMed ID: 10845658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting results of coulometry and immunoprecipitation in diagnosing iron disorders.
    Rettmer RL; Labbé RF; Huebers HA; Brown WP; Josephson BM; Finch CA
    Clin Chem; 1987 Jul; 33(7):1215-6. PubMed ID: 3297421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
    de Swart L; Hendriks JC; van der Vorm LN; Cabantchik ZI; Evans PJ; Hod EA; Brittenham GM; Furman Y; Wojczyk B; Janssen MC; Porter JB; Mattijssen VE; Biemond BJ; MacKenzie MA; Origa R; Galanello R; Hider RC; Swinkels DW
    Haematologica; 2016 Jan; 101(1):38-45. PubMed ID: 26385212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific iron in patients with beta-thalassaemia trait and chronic active hepatitis.
    Fargion S; Cappellini MD; Sampietro M; Fiorelli G
    Scand J Haematol; 1981 Feb; 26(2):161-7. PubMed ID: 7256213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description.
    Büyükaşik NS; Nadır I; Akin FE; Cakal B; Kav T; Ersoy O; Büyükaşik Y
    Turk J Gastroenterol; 2011 Dec; 22(6):606-11. PubMed ID: 22287406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum iron parameters in chronic liver diseses].
    Wójtowicz-Chomicz K; Cichoz-Lach H; Lis E; Kowalik A; Słomka M; Celiński K
    Pol Merkur Lekarski; 2013 Aug; 35(206):77-81. PubMed ID: 24052985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.
    Chow LH; Frei JV; Hodsman AB; Valberg LS
    Gastroenterology; 1985 Apr; 88(4):865-9. PubMed ID: 3838288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis.
    Beamish MR; Walker R; Miller F; Worwood M; Jacobs A; Williams R; Corrigall A
    Br J Haematol; 1974 Jun; 27(2):219-28. PubMed ID: 4843672
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-transferrin-bound iron in alcohol abusers.
    De Feo TM; Fargion S; Duca L; Cesana BM; Boncinelli L; Lozza P; Cappellini MD; Fiorelli G
    Alcohol Clin Exp Res; 2001 Oct; 25(10):1494-9. PubMed ID: 11696670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-transferrin-bound iron in 4 patients with excessive amounts of iron in the blood].
    Vernet-Nyssen M; Abramian S; Girard D; Bel A
    Nouv Presse Med; 1982 Dec; 11(50):3725-6. PubMed ID: 7170173
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron metabolism in hereditary hemochromatosis].
    Andreeva AP; Levina AA; Sattarova DA; Tsibul'skaia MM; Tokarev iuN
    Vrach Delo; 1989 Apr; (4):65-9. PubMed ID: 2756692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
    Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
    Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.